Mandelia Ashish

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return8%12%0%0%0%
Sale Success Rate1 of 41 of 40 of 40 of 40 of 4

Mersana Therapeutics, Inc.

Other » Other

VP, Chief Accounting Officer:

Holdings: 47.76K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--